This content is from: Patents

USPTO, AbbVie, Amgen, ITC, design patents – the week in IP

Recent intellectual property news included a proposal to make the USPTO an independent agency, a record year for US patent issuance, a settlement of AbbVie and Amgen’s Humira biosimilar dispute, a surge of complaints at the International Trade Commission, and the first post-Samsung verdict on design patent damages

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.